CMS Says No To PET For Alzheimer’s, But Leaves Door Open For Future Studies
This article was originally published in The Gray Sheet
Executive Summary
CMS continues to support research on FDG-PET in the diagnosis of Alzheimer's disease (AD), despite an April 16 non-coverage decision